Is Immortality Possible?
Recently a lot of media attention has been paid to apparently wild claims of some scientists regarding possible human immortality.
These researchers claim that with new biotechnological advances the human aging could be defeated in the near future, and that we could stay healthy and vigorous for many more years.
Is it a hype and a wishful thinking?
Or perhaps there may be something here, that deserves careful consideration for possible serious investments and philanthropic support?
In this initiative we suggest to establish a network of qualified impartial scientists who will carefully review and evaluate the existing claims and supporting evidence for feasibility of life-extension. A team of experts will study not only the media reports, but also the original scientific publications and evaluate their scientific merit.
Scientific experts will also attend the anti-aging and life-extension professional meetings, and will make site visits to researcher's labs.
The results of these investigations will be made public through this website, published articles and blogs elsewhere.
This project will also allow to organize a continuos monitoring for ongoing scientific developments and breakthroughs that have a real potential for further extension of healthy lifespan (for possible subsequent investments and philanthropic support).
The proof that we are qualified to accomplish this project is available here: http://longevity-science.org/CV-gavrilov.htm
Please pass this message to the attention of potential sponsors and philanthropists you may know.
Dr. Leonid A. Gavrilov,Ph.D.
Center on Aging
NORC/University of Chicago
1155 East 60th Street
Chicago, IL 60637-2745
Fax: (773) 256-6313,
Phone: (773) 256-6359
Dr. Leonid Gavrilov is one of the world's leading experts in longevity studies, and the author of a well-respected scientific book, "The Biology of Life Span", listed in the Encyclopedia Britannica as a recommended reference. He has Ph.D. in genetics and M. Sc. in chemistry, both from the Moscow State University, Russia.
Dr. Gavrilov is the founder of a new reliability theory of aging and longevity.
Leonid Gavrilov is a Principal Investigator of the scientific project "Biodemography of Human Longevity", funded by the National Institute on Aging (USA), and the author of over a hundred of scientific publications on related topic.
Dr. Gavrilov is the Associate Editor of scientific journals "Experimental Gerontology" and "Theoretical Biology and Medical Modelling." He is also an Editorial Board member of scientific journals "Rejuvenation Research", "The Scientific World Journal" and "Journal of Anti-Aging Medicine."
Leonid Gavrilov is a referee for over 20 scientific journals on aging and longevity studies including AGE (Journal of the American Aging Association), Annals of Human Genetics, Biogerontology, Biology Letters (Royal Society), BioMed Central, Demography, European Journal of Population, Experimental Gerontology, Genus, International Journal of Epidemiology, Journal of Anti-Aging Medicine, Journal of Gerontology, Journal of the American Geriatrics Society, Journal of Theoretical Biology, Mathematical Population Studies, Population, Population and Development Review, Rejuvenation Research, Social Biology, Sociological Methodology, The Scientific World Journal.
He is also an Expert for the National Institute on Aging (USA), the National Research Council at the National Academy of Sciences (USA), Canadian Institutes of Health Research (CIHR), and the Austrian Science Fund (FWF).
Dr. Gavrilov has been a keynote speaker at several conferences including the International Conference on Longevity (Sydney, Australia, 2004). He gives invited scientific lectures worldwide: England, France, Germany, Japan, Italy, Belgium, Netherlands, Russia, and of course in the United States (including invited presentations at the National Institute on Aging, NIH).
Dr. Gavrilov is a member of the Gerontological Society of America, International Union for the Scientific Study of Population, Population Association of America, and the Science Advisory Board (Steering Committee).